RxDoctor Payments Data

Carson Close, PA

Physician Assistant · Ogden, UTNPI 1073981437

Payments from drug & device makers

$4,359in general payments, 2019–2025

Across 269 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$946
  • Lilly USA, LLC$608
  • Amgen$281
  • Johnson & Johnson$221
  • GSK$221
  • AstraZeneca$214
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$4,359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,359 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$87,909
Medicare patients
409
Services billed
6,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$51,351
JardianceEmpagliflozin30$41,742
FarxigaDapagliflozin Propanediol32$33,271
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$23,479
EliquisApixaban19$22,308
XareltoRivaroxaban26$21,610
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$14,841
JanuviaSitagliptin Phosphate15$10,270
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,630
Albuterol Sulfate HfaAlbuterol Sulfate82$2,630
Atorvastatin Calcium160$1,742
Omeprazole96$1,682
Celecoxib59$1,563
Fluticasone Propionate89$1,256
Levothyroxine Sodium147$1,117

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Xarelto$221$72,96140 claims
AstraZenecaFarxiga, Breztri Aerosphere$214$48,11243 claims
Boehringer IngelheimJardiance$95$41,74230 claims
GSKTrelegy Ellipta$221$23,47924 claims
PfizerEliquis$214$22,30819 claims
MerckJanuvia$35$10,27015 claims
Lilly USA, LLCOlanzapine$608$42812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →